文献速递儿科与产科急症重症综合管理与镇静镇痛

口服昂丹司琼减少儿童经鼻芬太尼联合笑气程序化镇静相关呕吐的随机对照试验

Oral Ondansetron to Reduce Vomiting in Children Receiving Intranasal Fentanyl and Inhaled Nitrous Oxide for Procedural Sedation and Analgesia: A Randomized Controlled Trial.
PubMed 文献 · Ann Emerg Med · 2020-01-24
一句话结论在儿科急诊以经鼻芬太尼联合笑气行程序化镇静时,预防性口服昂丹司琼未显著降低早期呕吐发生率(12% vs 16%,P=.18)。

该双盲随机对照试验在单中心三级儿科急诊开展,纳入3至18岁计划以经鼻芬太尼联合笑气行程序化镇静的儿童,随机在笑气给药前30至60分钟口服昂丹司琼或安慰剂。共招募442例、436例纳入分析,主要终点早期呕吐(笑气给药期间或给药后1小时内)昂丹司琼组12% vs 安慰剂组16%,差值-4.6%(95%CI -11%至2.0%;P=.18),无显著差异。91%的镇静被治疗医生评为最佳,仅安慰剂组出现2例轻微不良事件。结论为口服昂丹司琼不能显著减少该方案相关的早期呕吐。

要点

  • 3至18岁儿童以经鼻芬太尼联合笑气行程序化镇静时,预防性口服昂丹司琼未显著降低早期呕吐(12% vs 16%,P=.18)。
  • 早期呕吐定义为笑气给药期间或给药后1小时内,两组差值-4.6%(95%CI -11%至2.0%),未达统计学显著。
  • 镇静后1至24小时呕吐、镇静时长、不良事件及镇静质量两组间比较为次要终点,原文未报告具体结果数值。
  • 91%的镇静被治疗医生评为最佳,仅安慰剂组发生2例轻微不良事件。
  • 该研究为单中心、双盲随机对照试验,结果需结合原文报告的人群与条件解读。

适用人群与场景

  • 3至18岁、计划以经鼻芬太尼联合笑气行程序化镇静的儿童,就诊于单中心三级儿科急诊。

诊断标准与关键阈值

  • 早期呕吐定义为笑气给药期间或给药后1小时内发生的呕吐。

处置流程与药物剂量

  • 昂丹司琼组在笑气给药前30至60分钟口服昂丹司琼,安慰剂组同时间口服安慰剂;原文未报告昂丹司琼具体剂量。

研究设计与关键结果

  • 双盲随机对照试验,单中心三级儿科急诊,招募442例、436例纳入分析,比较口服昂丹司琼与安慰剂。
  • 主要终点早期呕吐:昂丹司琼组12% vs 安慰剂组16%,差值-4.6%(95%CI -11%至2.0%;P=.18),无显著差异。
  • 次要终点包括镇静后1至24小时呕吐、镇静时长、不良事件及镇静质量,原文未报告具体结果数值。
  • 91%的镇静被治疗医生评为最佳;仅2例轻微不良事件,均发生于安慰剂组。

证据类型、等级与局限

  • 证据类型:双盲随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于3至18岁以经鼻芬太尼联合笑气行程序化镇静的儿童,预防性口服昂丹司琼未显著减少早期呕吐,原文结论不支持将其作为常规预防措施。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: Intranasal fentanyl and inhaled nitrous oxide are increasingly combined to provide procedural sedation and analgesia in the pediatric emergency setting. This regimen is attractive because of its nonparenteral administration, but is associated with a higher incidence of vomiting than nitrous oxide alone. We seek to assess whether prophylactic oral ondansetron use could reduce the incidence of vomiting associated with intranasal fentanyl and nitrous oxide for procedural sedation compared with placebo.

METHODS: This was a double-blind, randomized controlled trial of oral ondansetron versus placebo conducted at a single tertiary care pediatric emergency department. Children aged 3 to 18 years with planned sedation with intranasal fentanyl and nitrous oxide were randomized to receive oral ondansetron or placebo 30 to 60 minutes before nitrous oxide administration. The primary outcome was early vomiting associated with procedural sedation, defined as occurring during or up to 1 hour after nitrous oxide administration. Secondary outcomes included vomiting 1 to 24 hours after procedural sedation, procedural sedation duration, adverse events, and quality of sedation across the 2 groups.

RESULTS: We recruited 442 participants and 436 were included for analysis. There was no significant difference in the primary outcome, early vomiting associated with procedural sedation, between the groups: ondansetron 12% versus placebo 16%, with a difference in proportions of -4.6% (95% confidence interval -11% to 2.0%; P=.18). Most sedations were reported as optimal by treating clinicians (91%). Only 2 minor adverse events occurred, both in the placebo group.

CONCLUSION: Oral ondansetron does not significantly reduce vomiting during or shortly after procedural sedation with combined intranasal fentanyl and inhaled nitrous oxide.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Fauteux-Lamarre E, McCarthy M, Quinn N, et al. Oral Ondansetron to Reduce Vomiting in Children Receiving Intranasal Fentanyl and Inhaled Nitrous Oxide for Procedural Sedation and Analgesia: A Randomized Controlled Trial. Ann Emerg Med. 2020. PMID: 31983494. doi:10.1016/j.annemergmed.2019.11.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。